Afatinib vs Montelukast

## Afatinib vs Montelukast: Overview

This comparison examines the pharmacological differences between **Afatinib** and **Montelukast**.

## Mechanism of Action

**Afatinib**: Irreversible covalent inhibitor of ErbB family (EGFR/HER1, HER2, HER4) tyrosine kinases.

**Montelukast**: Selective leukotriene D4 receptor antagonist.

## Pharmacokinetics

**Half-life**: Afatinib — 37 hours; Montelukast — 2.7-5.5 hours.

## Chemical Properties

**Molecular Formula**: Afatinib — C24H25ClFN5O3; Montelukast — C35H36ClNO3S.

**Molecular Weight**: Afatinib — 485.9400 g/mol; Montelukast — 586.1800 g/mol.

**Type**: Afatinib — Small molecule; Montelukast — Small molecule.